GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ananda Pharma PLC (STU:1FX) » Definitions » Cash Flow from Discontinued Operations

Ananda Pharma (STU:1FX) Cash Flow from Discontinued Operations : €0.00 Mil (TTM As of Jul. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Ananda Pharma Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

Ananda Pharma's cash flow from discontinued operations for the six months ended in Jul. 2024 was €0.00 Mil. It means Ananda Pharma received €0.00 Mil from the sale of part of business quarterly. Ananda Pharma's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Jul. 2024 was €0.00 Mil.

Ananda Pharma Cash Flow from Discontinued Operations Historical Data

The historical data trend for Ananda Pharma's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ananda Pharma Cash Flow from Discontinued Operations Chart

Ananda Pharma Annual Data
Trend Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Cash Flow from Discontinued Operations
Get a 7-Day Free Trial - - - - -

Ananda Pharma Semi-Annual Data
Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24 Jul24
Cash Flow from Discontinued Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Ananda Pharma Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Jul. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ananda Pharma Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of Ananda Pharma's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

Ananda Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ananda Pharma PLC (STU:1FX) » Definitions » Cash Flow from Discontinued Operations
Comparable Companies
LSE:PXS LSE:STX LSE:N4P LSE:CEL LSE:EAH ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA SHSE:688506 BOM:500087 SZSE:000538 TSE:4507 UTHR
Traded in Other Exchanges
ANA:UK
Address
60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Website
https://www.anandapharma.co.uk
Ananda Pharma PLC is focused on the development of cannabinoid therapies for the treatment of a range of complex conditions. The company is developing NHS-approved and MHRA-licensed cannabinoid medicines for the treatment of drug-resistant epilepsies and specific inflammatory pain conditions (starting with CIPN & endometriosis) and HFpEF heart failure.

Ananda Pharma Headlines

No Headlines